A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Recruiting · NCT07321106 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal cancer, colorectal carcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm, rectal disorder | Recruiting | Phase 1 | 2026-08-26 | NCT07321106 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cartography Biosciences | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope Duarte | Duarte | United States | 5 |
| Emory Winship Cancer Institute | Atlanta | United States | 29 |
| Mayo Clinic Arizona | Phoenix | United States | 55 |
| Mayo Clinic Florida | Jacksonville | United States | 105 |
| NEXT Oncology | San Antonio | United States | 70 |
| NEXT Oncology | Fairfax | United States | 31 |
| START Midwest | Grand Rapids | United States | 79 |
| UCLA | Los Angeles | United States | 80 |
| UCSF | San Francisco | United States | 13 |
| Valkyrie Clinical Trials | Los Angeles | United States | 1 |